Policy swings have made it a slippery year for pharma ...

SteQeyma™ 45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeymatm, a ...

People taking methotrexate for a variety of conditions have been warned by the NHS that a number of symptoms and side effects ...

Here’s what to know about how common bottom-of-foot pain is, why it happens and the most reliable ways to find relief.

Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...

Mom Elaine-Maree Telfer told Newsweek she felt "absolutely helpless," but knew she had to keep pushing for answers.

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...

The future of dermatology is no longer just skin deep. This year’s American Academy of Dermatology (AAD) annual meeting was held March 7-11, 2025, in Orlando, FL, and it showcased the specialty’s ...

Long-lasting drug-free remission for children and adults with inflammatory arthritis is a step closer to becoming a reality thanks to new collaboration.

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera ...